Table 2.
Baseline correlations between MRI measures and clinical cardiopulmonary variables in MS patients
| VO2max | HRR | HRrest | MWT6 | T25FW | ||
|---|---|---|---|---|---|---|
| T2-hyperintense WM LV | r-value | 0.057 | − 0.010 | − 0.162 | − 0.0204 | 0.094 |
| p-value | 0.668 | 0.941 | 0.220 | 0.125 | 0.506 | |
| NGMV | r-value | 0.245 | 0.052 | 0.170 | 0.259 | − 0.164 |
| p-value | 0.077 | 0.714 | 0.199 | 0.061 | 0.240 | |
| Left Insula T2-hyperintense LV | r-value | − 0.219 | 0.268 | − 0.079 | − 0.028 | 0.038 |
| p-value | 0.098 | 0.042 | 0.551 | 0.837 | 0.791 | |
| Right Insula T2-hyperintense LV | r-value | 0.074 | 0.230 | − 0.123 | 0.081 | 0.112 |
| p-value | 0.579 | 0.083 | 0.354 | 0.547 | 0.430 | |
| Left Insula volume | r-value | − 0.480 | 0.239 | 0.047 | − 0.40 | 0.148 |
| p-value | 0.719 | 0.071 | 0.723 | 0.768 | 0.294 | |
| Right Insula volume | r-value | − 0.069 | 0.207 | 0.054 | − 0.046 | 0.148 |
| p-value | 0.606 | 0.119 | 0.687 | 0.743 | 0.294 |
Statistically significant comparisons are shown in bold
bpm beats per minute, HRrest heart rate at rest, HRR heart rate reserve, IQR interquartile range, Kg kilograms, min minutes, mL milliliters, MS-A Multiple sclerosis (MS) patients that performed aerobic training, MS-C MS group that performed motor control training without direct involvement of cardiopulmonary system, MS-WL-A MS patients with baseline insula lesions that performed aerobic training, MS-WOL-A MS patients without baseline insula lesions that performed aerobic training, MS-WL-C MS patients with baseline insula lesions that performed motor control training, MS-WOL-C MS patients without baseline insula lesions that performed motor control training, WM white matter, NGMV normalized gray matter volume, T25FW timed 25-foot walk test, VO2max maximal oxygen consumption, 6MWT six-minute walk test